Holen Sie sich die Stockscreener-App
293.70
0.41%
-1.21
Schlusskurs vom Vortag:
$294.91
Offen:
$290.89
24-Stunden-Volumen:
173.16K
Relative Volume:
0.87
Marktkapitalisierung:
$7.92B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$-778.69M
KGV:
-10.75
EPS:
-27.33
Netto-Cashflow:
$223.75M
1W Leistung:
-0.97%
1M Leistung:
-3.55%
6M Leistung:
+17.44%
1J Leistung:
-18.16%
1-Tages-Spanne:
$289.19
$295.76
1-Wochen-Bereich:
$287.46
$302.59
52-Wochen-Spanne:
$211.43
$363.96
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Vergleichen Sie BIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
293.70 | 7.96B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
109.30 | 184.48B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.56 | 135.49B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
93.53 | 136.93B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
102.96 | 129.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.36 | 47.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Chromatography Research Report 2026 - GlobeNewswire Inc.
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 - BioSpace
Universal Beteiligungs und Servicegesellschaft mbH Has $3.63 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
North America Gas Chromatography Market Forecast Report - GlobeNewswire
North America Gas Chromatography Market Forecast Report 2025-2033 Featuring Agilent, Bio-Rad, Chromatotec, Merck, PerkinElmer, Phenomenex, Restek, Shimadzu, Thermo Fisher Scientific, Waters - Yahoo Finance
United States Electroporation Instruments and Consumables - openPR.com
Shigella Test Kit Market 2026 Is Booming Worldwide by 2033 - openPR.com
Difficult-to-Express Proteins Market to Reach USD 9.05B by 2031 - openPR.com
Bank Watch: Is Bio Rad Laboratories Incs ROE strong enoughStock Surge & Weekly Top Gainers Trade List - baoquankhu1.vn
Incredible Growth of Cancer Monoclonal Antibodies Market - openPR.com
Cell Culture Media Market Covering Prime Factors - openPR.com
Biomarkers Market to Reach US$ 148.88B by 2032 | CAGR 11.9% | North - openPR.com
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Income Plays: Is XFLTPRA a good ESG investmentWeekly Trade Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
Sector Gamma AS Buys 4,998 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Performance Recap: Can Bio Rad Laboratories Inc generate free cash flowWeekly Market Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Rapid Food Safety Testing Growth Driven by SGS Leadership - Market.us
Thermal Cycler Market Market Set to Boom: Strategic Insights - openPR.com
Is Bio-Rad Laboratories (BIO) Starting To Look Attractive After Prolonged Share Price Weakness? - Sahm
Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth - Seeking Alpha
Cell Counting System Market Overview and Leading Players: - openPR.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Proteomics Market Dynamics and Contributions by Thermo Fisher - openPR.com
Qiagen Explores Possible Sale After New Buyer Talks: Report - Sahm
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now - TradingView
Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com
United States Protein Labeling Market Growth (2025-2032): Key - openPR.com
Lab on Chip Market Set for Dynamic Development with Key Players - openPR.com
Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
AI Stocks: Is Bio Rad Laboratories Inc likely to announce a buybackNew Guidance & Long-Term Investment Growth Plans - baoquankhu1.vn
Trading Action: Can Bio Rad Laboratories Inc generate free cash flowJuly 2025 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Protein Chip Market to Reach US$ 7.6 Billion by 2032 at 15.9% CAGR; - openPR.com
Bio-Rad Laboratories Is Quietly Eating the Lab World – But Is BIO Stock Worth Your Cash? - AD HOC NEWS
Blood Screening Market Outlook 2026-2033: Technological - openPR.com
Microfluidics Market to Reach US$ 73.97 Billion by 2032 at 12.6% - openPR.com
Revenue Check: How correlated is Bio Rad Laboratories Inc to the S P5002025 Macro Impact & Verified Trade Idea Suggestions - baoquankhu1.vn
DNA/RNA Extraction Kit Market to Reach US$ 6.9 Billion by 2032 - openPR.com
SG Americas Securities LLC Buys 5,600 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Fund Flows: Can RF Acquisition Corp II Debt Equity Composite Units ride the EV waveMarket Trend Report & Expert Verified Movement Alerts - baoquankhu1.vn
DNA Extraction Kits Market Growth Outlook: Booming - openPR.com
Laboratory Equipment and Disposables Market is expected - openPR.com
Surprises Report: Will Bio Rad Laboratories Inc stock maintain growth story - Bộ Nội Vụ
Income Plays: What drives Bio Rad Laboratories Incs stock price2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
Why retail investors pile into Bio Rad Laboratories Inc stock2025 Winners & Losers & Fast Moving Trade Plans - Bộ Nội Vụ
Bio-FET Market to Witness 8.5% CAGR by 2033: Abbott - openPR.com
Entry Recap: Can Bio Rad Laboratories Inc Class stock surprise with quarterly resultsMarket Weekly Review & Weekly Top Gainers Trade List - Bộ Nội Vụ
Epigenetics Market Booming with Rapid Growth Through 2033 | F. - openPR.com
Will Bio Rad Laboratories Inc. stock recover faster than marketJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - ulpravda.ru
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed actionJuly 2025 PreEarnings & Consistent Growth Stock Picks - Улправда
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):